<SEC-DOCUMENT>0001193125-21-236407-index.html : 20210804
<SEC-HEADER>0001193125-21-236407.hdr.sgml : 20210804
<ACCEPTANCE-DATETIME>20210804171100
ACCESSION NUMBER:		0001193125-21-236407
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20210804
DATE AS OF CHANGE:		20210804
GROUP MEMBERS:		BCIP LIFE SCIENCES ASSOCIATES, LP
GROUP MEMBERS:		BCLS II INVESTCO, LP

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nuvalent, Inc.
		CENTRAL INDEX KEY:			0001861560
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92743
		FILM NUMBER:		211145099

	BUSINESS ADDRESS:	
		STREET 1:		ONE BROADWAY, 14TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		508-446-2272

	MAIL ADDRESS:	
		STREET 1:		ONE BROADWAY, 14TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bain Capital Life Sciences Fund II, L.P.
		CENTRAL INDEX KEY:			0001773187
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D

	BUSINESS ADDRESS:	
		STREET 1:		200 CLARENDON STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		6175162000

	MAIL ADDRESS:	
		STREET 1:		200 CLARENDON STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>d243821dsc13d.htm
<DESCRIPTION>SC 13D
<TEXT>
Document 1 - file: d243821dsc13d.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.A
<SEQUENCE>2
<FILENAME>d243821dex99a.htm
<DESCRIPTION>EX-99.A
<TEXT>
Document 2 - file: d243821dex99a.htm

</DOCUMENT>
</SEC-DOCUMENT>